Novo Nordisk A/S NVO
41.63 USD +0.98 (+2.41%)
Regular-session close
41.44 -0.19 -0.46%
After hours · Nov 13, 7:59 PM ET
40.64 Day range 41.80
35.29 52-week range 63.98
- YTD
- -18.18%
- 1 year
- -15.32%
Discussion (212)
Sign in to join the discussion
Always overcharged in the U.S. for Ozempic
Seniors now pay 80% more for Ozempic with Advantage C programs. This company is done.
How the f would you know if it hits 62 mr analyst
F miss Isabella
Scripts are sky rocketing
Vktx is just a little shit in the woods VS NVO
57$ and some change at Robin Hood now
Nvo can’t make more money for the blue chip stock if they keep dropping the product pricing.
NVO 的减重药物已获批准,整体发展进入正面阶段。上个月在 43 美元附近布局的仓位,目前已经反弹至约 52 美元。如果后续进展顺利,NVO 的长线目标仍看向 70 美元。恭喜各位持有者
